Elshenawy Mohamed 4

4 · Hims & Hers Health, Inc. · Filed Jun 17, 2026

AI-generated summary of this filing

Updated Jun 17, 2026

Hims & Hers (HIMS) CTO Mohamed Elshenawy Sells Shares

What Happened

Mohamed Elshenawy, Chief Technology Officer at Hims & Hers (HIMS), reported the vesting/settlement of RSUs and subsequent share dispositions. On June 15, 2026, 282,597 RSUs were converted/settled. To cover tax withholding obligations, 151,534 shares were withheld by the issuer (value reported $4,571,781). On June 17, 2026, Elshenawy sold 30,040 shares in an open-market transaction at $31.50 per share for proceeds of $946,260. The filing also reports additional derivative-related settlements of 259,084 and 23,513 shares (reported with $0 exercise price, reflecting RSU settlement).

Key Details

Transaction dates and prices:
- June 15, 2026: RSU vest/settlement (282,597 RSUs converted); 151,534 shares withheld for taxes at implied value $30.17 ($4,571,781).
- June 17, 2026: Open-market sale of 30,040 shares at $31.50 ($946,260).
- Additional RSU/derivative settlements of 259,084 and 23,513 shares reported at $0.00 (reflecting RSU settlement).
Combined reported value related to these actions: approximately $5.52M (withheld value + sale proceeds).
Shares owned after the transactions: not specified in the provided filing.
Notable footnotes:
- F1/F4/F5: These were RSUs (one RSU = one share) subject to a 4‑year service-based vesting schedule with an initial vest on June 15, 2026 and subsequent quarterly vesting.
- F2: The 151,534 shares were withheld by the issuer to satisfy tax-withholding obligations.
- F3: The open-market sales were executed under a Rule 10b5-1 trading plan adopted December 1, 2025.
Filing timeliness: Reported on Form 4 filed June 17, 2026 for transactions occurring June 15–17, 2026 (appears timely).

Context

These entries reflect RSU vesting and settlement (derivative conversions) followed by routine tax withholding and a planned sale under a 10b5-1 plan. RSU settlements reported at $0.00 exercise price indicate no option exercise cost (they were awarded as RSUs and converted to shares).
Tax-withheld shares are not a market-sale by the insider but a net settlement to cover withholding. The open-market sale is a realized disposition and was executed under a pre-established trading plan.
This is standard executive compensation activity rather than an outright purchase; purchases are generally more informative as bullish signals.

Form 4

Period: 2026-06-15

CTO

Transactions

Exercise/Conversion
Class A Common Stock
[F1]
2026-06-15+282,597→ 282,597 total
Tax Payment
Class A Common Stock
[F2]
2026-06-15$30.17/sh−151,534$4,571,781→ 131,063 total
Sale
Class A Common Stock
[F3]
2026-06-17$31.50/sh−30,040$946,260→ 101,023 total
Exercise/Conversion
Restricted Stock Unit
[F1][F4]
2026-06-15−259,084→ 777,255 total
→ Class A Common Stock (259,084 underlying)
Exercise/Conversion
Restricted Stock Unit
[F1][F5]
2026-06-15−23,513→ 352,709 total
→ Class A Common Stock (23,513 underlying)

Footnotes (5)

[F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
[F2]The shares of Class A Common Stock were withheld by the issuer to cover tax withholding obligations in connection with the reported vesting and settlement of RSUs.
[F3]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on December 1, 2025 by the Reporting Person.
[F4]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with 25% of the RSUs vesting on June 15, 2026, and the remaining 75% of the RSUs vesting in substantially equal quarterly installments thereafter on the Company's quarterly vesting dates.
[F5]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 4-year period, with the RSUs vesting in substantially equal quarterly installments on the Company's quarterly vesting dates, with the first such vesting date on June 15, 2026.

Signature

/s/ Kimberly Mather, Attorney-in-Fact for Mohamed Elshenawy|2026-06-17

1 file